Literature DB >> 12782913

Cholinergic-dopaminergic imbalance in Pisa syndrome.

Alberto Villarejo1, Ana Camacho, Rocío García-Ramos, Teresa Moreno, Marta Penas, Raúl Juntas, Juan Ruiz.   

Abstract

Pisa syndrome is a rare type of truncal dystonia. Its development is associated commonly with neuroleptic treatment, but there are rare idiopathic cases or those related to neurodegenerative disorders. Recently, an association between cholinesterase inhibitors and Pisa syndrome has been described. The authors report two patients, one with Alzheimer's disease treated with risperidone and another with Parkinson's disease who presented this kind of dystonia after donepezil initiation. In the first patient the condition resolved after discontinuation of risperidone, and in the second one the condition resolved when donepezil was withdrawn. In patients with pharmacologic or degenerative dopaminergic neurotransmission disorders, cholinergic excess may induce this peculiar type of dystonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782913     DOI: 10.1097/00002826-200305000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  17 in total

1.  Clinical heterogeneity and underlying pathophysiological mechanisms of lateral flexion of the trunk in Parkinson's disease.

Authors:  Eduardo de Pablo-Fernández; Alberto Villarejo-Galende
Journal:  J Neurol       Date:  2011-09-28       Impact factor: 4.849

2.  Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.

Authors:  Andrea Santamato; Maurizio Ranieri; Francesco Panza; Stefano Zoccolella; Vincenza Frisardi; Vincenzo Solfrizzi; Maria Teresa Amoruso; Loredana Amoruso; Pietro Fiore
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

3.  Reversible Parkinsonism and Pisa Syndrome in Juvenile Normal Pressure Hydrocephalus.

Authors:  Sanjay Pandey
Journal:  Mov Disord Clin Pract       Date:  2014-12-30

4.  Donepezil induced antecollis in a patient with Parkinson's disease dementia.

Authors:  Yoon-Sang Oh; Joong-Seok Kim; Dong Woo Ryu; Kwang-Soo Lee
Journal:  Neurol Sci       Date:  2012-11-23       Impact factor: 3.307

Review 5.  An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine.

Authors:  Rita Khoury; Jayashree Rajamanickam; George T Grossberg
Journal:  Ther Adv Drug Saf       Date:  2018-01-08

6.  Primary and Reversible Pisa Syndrome in Juvenile Normal Pressure Hydrocephalus.

Authors:  Fidias E Leon-Sarmiento; Gustavo Pradilla; Maria Del Rosario Zambrano
Journal:  Acta Neuropsychiatr       Date:  2013-02-01       Impact factor: 3.403

Review 7.  Lateral flexion in Parkinson's disease and Pisa syndrome.

Authors:  Fusako Yokochi
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

8.  Etiology and Management of Spinal Deformity in Patients With Parkinson's Disease.

Authors:  Roy Ruttiman; Adam E M Eltorai; Alan H Daniels
Journal:  Int J Spine Surg       Date:  2018-03-30

9.  Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.

Authors:  Antonino Cannas; Paolo Solla; Gianluca Floris; Paolo Tacconi; Alessandra Serra; Mario Piga; Francesco Marrosu; Maria Giovanna Marrosu
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

Review 10.  Postural, Bone, and Joint Disorders in Parkinson's Disease.

Authors:  Marcie L Rabin; Mary Cathryn Earnhardt; Anvi Patel; Ivana Ganihong; Roger Kurlan
Journal:  Mov Disord Clin Pract       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.